windtree therapeutics inc k jun    pm  seeking alphasign in  join nowgo»windtree therapeutics inc wintform k  current reportjun    pmabout windtree therapeutics inc wintview as pdf windtree therapeutics inc de form k received       united states securities and exchange commission washington dc      form k   current report   pursuant to section  or d of the securities exchange act of    june    date of report date of earliest event reported   windtree therapeutics inc exact name of registrant as specified in its charter   delaware   state or other jurisdiction of incorporation commission file number irs employer identification number    kelly road suite  warrington pennsylvania  address of principal executive offices   registrants telephone number including area code   former name or former address if changed since last report   check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions    written communications pursuant to rule  under the securities act  cfr   soliciting material pursuant to rule a under the exchange act  cfr a  precommencement communications pursuant to rule db under the exchange act  cfr db  precommencement communications pursuant to rule ec under the exchange act  cfr ec     item  entry into a material definitive agreement    effective june   the “ effective date ” windtree therapeutics inc the “ company ” entered into a license development and commercialization agreement “ license agreement ” with lee’s pharmaceutical hk ltd a company organized under the laws of hong kong  “lee’s ” under the license agreement the company has granted to lee’s an exclusive license with a right to sublicense i to develop and commercialize the company’s kl  surfactant products including surfaxin ®  which was approved by the us food and drug administration “ fda ” in  for the prevention of respiratory distress syndrome “ rds ” in premature infants surfaxin ls ™  the lyophilized dosage form of surfaxin and aerosurf ®  the company’s investigative combination drugdevice product that is designed to deliver aerosolized kl   surfactant noninvasively and ii to register and manufacture surfaxin and surfaxin ls for use in the licensed territory which includes the people’s republic of china “ prc ” hong kong thailand taiwan and  other countries the “ licensed territory ” in addition the company has granted lee’s options to potentially add japan to the licensed territory and to manufacture the company’s aerosol delivery device in the licensed territory in each case subject to conditions set forth in the license agreement   under the license agreement lee’s will make an upfront payment to the company of  million on or before july   lee’s also invested  million in the company’s recent private placement of convertible preferred stock units that was effective february   the company also may receive up to  million in potential  clinical regulatory and commercial milestone payments the company also will share in any sublicense income lee’s may receive at a rate equal to low double digits in addition lee’s will be responsible for all costs and expenses in and for the licensed territory related to development activities including a planned aerosurf phase  clinical trial regulatory activities and commercialization activities   t he company also will be eligible to receive tiered royalties based on a percent of net sales depending on the product  in the range of high single to lowtomid double digit percentages royalties are payable on a countrybycountry basis until the latest of a the expiration of the last valid patent claim covering the product in the country of sale b the expiration or revocation of any applicable regulatory exclusivity in the country of sale and c ten  years after the first commercial sale in the country of sale thereafter in consideration of licensed rights other than patent rights royalties shall continue for the commercial life of each product and for the initial three years shall be in the range of lowtomid single digits in addition in the event that one or more generic products are introduced the royalty rates will be reduced subject to certain minimums if the company has continuing obligations at the time to pay royalties under its inlicense agreements   under the license agreement lee’s will be responsible for all activities related to development regulatory approval and commercialization of the company’s kl  surfactant and combination drug  device products in the licensed territory lee’s will hold the product licenses for all nonaerosolized products in the licensed territory and will seek regulatory approval initially for surfaxin and surfaxin ls for rds the company will hold the product license in the licensed territory except where prohibited by law for all aerosolized products and will designate lee’s its exclusive agent and representative to develop and register aerosurf and other aerosolized products in the name of and on behalf of the company lee’s also has agreed that except as provided in the license agreement for a period of ten  years beginning with the later of the first commercial sale of the first aerosolized product and the first commercial sale of the first nonaerosolized product in the prc it will not develop register manufacture or commercialize any product for the prevention andor treatment of rds in premature infants or other diseases and conditions in humans in either case that administers utilizes or contains pulmonary surfactant without the company’s prior written consent   under the license agreement the company and lee’s will establish a joint steering committee “jsc” to oversee the development registration and commercialization of the products in the licensed territory in addition the company and lee’s will establish a joint development committee to prepare and oversee the development plan for the licensed territory and at the appropriate time a joint commercialization committee to implement a commercialization plan and oversee the commercialization of approved products in the licensed territory   lee ’s may sublicense certain activities under the license agreement to an affiliate of lee’s but may not grant sublicenses to unaffiliated third parties without the prior consent of the company a sublicensee and a subcontractor may not be a competitor identified by the company sublicenses under the license agreement do not include the right to further sublicense in addition the company and lee’s plan to negotiate i a technology transfer agreement under which the company will transfer to lee’s the manufacturing processes for surfaxin and surfaxin ls ii a manufacturing agreement providing for the manufacture of surfaxin and surfaxin ls by lee’s and giving the company access to such products outside the licensed territory iii a manufacturing and supply agreement providing for the manufacture and supply of aerosurf drug and medical device components by the company to lee’s and iv such other agreements and amendments as may be necessary for the parties to perform their obligations under the license agreement   the term of the license agreement commenced on the effective date and will continue on a countrybycountry basis for the commercial life of the products either party may terminate the license agreement in the event of bankruptcy or a material breach of the license agreement by the other party that remains uncured for a period of sixty  days in addition either party may terminate the license agreement in its entirety or with respect to any individual product or country if a regulatory authority terminates suspends or discontinues development of a product and such termination suspension or discontinuance persists for a period in excess of eighteen  months upon termination of the license agreement in its entirety or with respect to a particular product or country generally all related rights and licenses granted to lee’s will terminate all rights under the company’s technology will revert to the company and lee’s will cease all use of the company’s technology   the foregoing description of the license agreement does not purport to be complete and is qualified in its entirety by reference to the license agreement which is expected to be filed with the securities and exchange commission “sec” as an exhibit to the quarterly report on form q for the quarter ended june   the license agreement will be filed to provide investors and the company’s stockholders with information regarding the terms thereof and in accordance with applicable rules and regulations of the sec pursuant to the license agreement each of the company and lee’s made customary representations warranties and covenants and agreed to indemnify each other for certain losses arising out of breaches of such representations warranties covenants and other specified matters the representations warranties and covenants were made by the parties to and solely for the benefit of each other and any expressly intended third party beneficiaries in the context of all of the terms and conditions of the agreements and in the context of the specific relationship between the parties accordingly investors and stockholders should not rely on the representations warranties and covenants furthermore investors and stockholders should not rely on the representations warranties and covenants as characterizations of the actual state of facts or continuing intentions of the parties since they were only made as of the date of the agreements information concerning the subject matter of such representations warranties and covenants may change after the date of the agreements which subsequent information may or may not be fully reflected in the company’s reports or other filings with the commission   item    other events   reference is made to item  on june   the company issued a press release and announced the execution and delivery of the license agreement described above the press release is attached as exhibit  to this current report on form k   in addition t he company will host a conference call and webcast including a slide presentation at  am edt on tuesday june   to discuss the license agreement and answer questions the live webcast including a slide presentation can be accessed at httpwindtreetxinvestorroomcomevents  to participate in the live call and take part in the question and answer session dial   domestic or   international   a replay of the conference call will be accessible one hour after completion through june   by dialing   domestic or   international and referencing conference number  an archive of the webcast can be accessed on the company ’s website at httpwindtreetxinvestorroomcomevents   item  financial statements and exhibits     d exhibits          press release dated june         cautionary note regarding forwardlooking statements   to the extent that statements in this current report on form k are not strictly historical including statements as to business strategy outlook objectives future milestones plans intentions goals future financial conditions future collaboration agreements the success of the company ’s product development or otherwise as to future events such statements are forwardlooking and are made pursuant to the safe harbor provisions of the private securities litigation reform act of  the forwardlooking statements contained in this current report are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made such risks and others are further described in the company’s filings with the securities and exchange commission including the most recent reports on forms k q and k and any amendments thereto     signatures   pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized     windtree therapeutics inc           by      s craig fraser                          craig fraser president and chief executive officer     date june     click to enlarge click to enlarge      windtree therapeutics and lee ’s pharmaceutical hk limited enter into exclusive license and collaboration agreement for develo pment and commercialization of kl  surfactant technology platform in asia   windtree and lee ’s collaborate to advance the development of aerosurf ®  surfaxin ® and surfaxin ls ™ in asia   windtree receives initial payments from lee’s totaling  million including a prior equity investment and an upfront l icense fee  with potential future milestone payments and development support totaling over  million plus royalties   windtree to host investor conference call tomorrow june   at  a m et   warrington pa and shatin hong kong – june    – windtree therapeutics inc otcqb wint a biotechnology company focused on developing aerosolized kl  surfactant therapies for respiratory diseases and lees pharmaceutical hk limited a whollyowned subsidiary of lees pharmaceutical holdings limited lees pharm sehk stock code  today announced that they have entered into an exclusive license and collaboration agreement for the development and commercialization of kl  surfactant products in select asian markets using windtree’s proprietary kl  surfactant and aerosolization technologies the agreement includes aerosurf ® as well as the nonaerosol products surfaxin ® approved in the us and surfaxin ls an improved lyophilized formulation of surfaxin also windtree has granted lee’s an exclusive license to manufacture kl  surfactant in china for use in nonaerosol surfactant products in the licensed territory   “ china and the surrounding asian markets represent a significant market opportunity for windtree and our kl  surfactant technology through our collaboration with lee’s we will be able to access and grow the kl  surfactant opportunity outside of the us and pursue development of aerosurf and our other kl  surfactant products with a proven partner” commented craig fraser president and chief executive officer of windtree therapeutics “i am excited about the potential of aerosurf to both transform and expand the management of respiratory distress syndrome rds worldwide and this collaboration with lee’s will significantly enhance our development and realization of this goal”   “ we are delighted to announce this collaboration with windtree given the size of the rds population and as a high growth current top surfactant market we are enthusiastic about our prospects to develop and market aerosurf and the other kl  surfactant products for our premature infants with rds” commented dr benjamin li chief executive officer of lee’s pharm “we also see real potential to address other acute pulmonary diseases and conditions and plan to explore these opportunities with windtree together with the group’s other assets this partnership will strengthen the group’s position in neonatal critical care”   in anticipation of finalizing the agreement lee ’s pharm invested  million in windtree’s february  private placement offering under terms of the license agreement windtree will receive an upfront license fee of  million and will also be eligible for up to  million in contingent clinical regulatory and commercialization milestone payments and escalating high single digit to midteens percentage royalties across all products in addition lee’s will be responsible for all development costs in the licensed territory   conference call and webcast details the company will host a conference call and webcast including a slide presentation at  am edt on tuesday june   to discuss this important collaboration with lee’s pharm   the live webcast including a slide presentation can be accessed at httpwindtreetxinvestorroomcomevents  to participate in the live call and take part in the question and answer session dial   domestic or   international   a replay of the conference call will be accessible one hour after completion through june   by dialing   domestic or   international and referencing conference number  an archive of the webcast can be accessed on the company’s website at httpwindtreetxinvestorroomcomevents    about windtree therapeutics windtree therapeutics inc is a clinicalstage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications windtrees proprietary technology platform includes a synthetic peptidecontaining surfactant kl  surfactant that is structurally similar to endogenous pulmonary surfactant and novel drugdelivery technologies being developed to enable noninvasive administration of aerosolized kl  surfactant windtree is focused initially on improving the management of respiratory distress syndrome rds in premature infants and believes that its proprietary technology may make it possible over time to develop a pipeline of kl  surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies   for more information please visit the companys website at wwwwindtreetxcom   about lees pharmaceutical holdings limited “ lee’s pharm” lee ’s pharm is a researchbased hong kong biopharmaceutical company listed in hong kong with more than  years of operation in chinas pharmaceutical industry it is fully integrated with strong infrastructures in drug development manufacturing sales and marketing it has established extensive partnership with more than  international companies and currently has  products in the market place lees pharm focuses on several key disease areas such as cardiovascular oncology gynecology dermatology and ophthalmology the company’s development program is lauded with over  products stemming from both internal rd efforts and collaborations with us european and japanese companies including promising compounds to treat diseases such as liver cancer and pulmonary hypertension the mission of lees pharm is to become a successful biopharmaceutical group in asia providing innovative products to fight diseases and improve health and quality of life   additional information about lee ’s pharm is available at wwwleespharmcom   forwardlooking statement for windtree therapeutics to the extent that statements in this press release are not strictly historical all such statements are forwardlooking and are made pursuant to the safe harbor provisions of the private securi ties litigation reform act of   these forwardlooking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made examples of such risks and uncertainties are described in windtrees filings with the securities and exchange commission including the most recent reports on forms k q and k and any amendments thereto   forwardlooking statement for lees pharm the performance and the results of operation of lee ’s pharm during the past years are historical in nature and past performance can be no guarantee of future results of the lee’s pharm this news release may contain forwardlooking statements and opinions that involve risks and uncertainties actual results may differ materially from expectations discussed in such forwardlooking statements and opinions neither lee’s pharm nor the directors employees or agents of lee’s pharm assume a any obligation to correct or update the forwardlooking statements or opinions contained in this news release and b any liability in the event that any of the forwardlooking statements or opinions does not materialize or turns out to be incorrect       contact information windtree therapeutics john tattory senior vice president and chief financial officer  or jtattorywindtreetxcom   lees pharm vivian fung licensing  regulatory manager  or infoleespharmcom     stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  windtree therapeutics inc company information  drugscom skip to content search all allconsumerprofessionalpill idinteractionsnewsfda alertsapprovalspipelineclinical trialscare notesencyclopediadictionarynatural products browse all medications a b c d e f g h i j k l m n o p q r s t u v w x y z advanced search topics  tools facebook twitter google plus sign in sign in register menu home › pharmaceutical companies › windtree therapeutics inc print share windtree therapeutics inc address windtree therapeutics inc  kelly road suite  warrington pa contact detailsphone  website wwwwindtreetxcomcareers wwwwindtreetxcomcareers latest drug information updates vosevi vosevi sofosbuvir  velpatasvir  voxilaprevir is a singletablet regimen for the treatment of adults withnerlynx nerlynx neratinib is a tyrosine kinase inhibitor for the extended adjuvant treatment of patients with earlytremfya tremfya guselkumab is an interleukin blocker indicated for the treatment of adult patients withbevyxxa bevyxxa betrixaban is an oral oncedaily factor xa inhibitor anticoagulant for the extendeddurationrituxan hycela rituxan hycela rituximab and hyaluronidase human is a subcutaneous monoclonal antibody and hyaluronidasebaxdela baxdela delafloxacin is a fluoroquinolone antibacterial indicated for the treatment of acute bacterial skin more drug information updates drugscom mobile apps the easiest way to lookup drug information identify pills check interactions and set up your own personal medication records available for android and ios devices explore apps support help center frequent questions sitemap contact us about about drugscom advertising policy content submissions drugscom blog terms  privacy editorial policy privacy policy terms of use attribution  citations facebook twitter google plus youtube rss feed subscribe to receive email notifications whenever new articles are published drugscom provides accurate and independent information on more than  prescription drugs overthecounter medicines and natural products this material is provided for educational purposes only and is not intended for medical advice diagnosis or treatment data sources include micromedex® updated july th  cerner multum™ updated july th  wolters kluwer™ updated july th  and others to view content sources and attributions please refer to our editorial policy third party advertising we comply with the honcode standard for trustworthy health information  verify here copyright   drugscom all rights reserved share on facebook share on twitter share on googleplus email to a friend hide stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one windtree therapeutics inc nasdaqwint files an k financial statements and exhibits  market exclusive sign in join home about us privacy policy disclaimer advertise on market exclusive about marketexclusivecom contributors sitemap submit a scoop contact us become a contributor stock market news stocks analyst ratings insider trading sec filings earnings biotech stocks small caps sign in welcomelog into your accountyour usernameyour password forgot your password sign up welcomeregister for an account your emailyour username a password will be emailed to you password recovery recover your passwordyour email search sign in  joinmy account orders sign inwelcome log into your accountyour usernameyour password forgot your password get helpcreate an account create an accountwelcome register for an accountyour emailyour username a password will be emailed to you password recoveryrecover your passwordyour email a password will be emailed to you market exclusive home about us privacy policy disclaimer advertise on market exclusive about marketexclusivecom contributors sitemap submit a scoop contact us become a contributor stock market news stocks analyst ratings insider trading sec filings earnings biotech stocks small caps home sec filings windtree therapeutics inc nasdaqwint files an k financial statements and exhibits sec filings windtree therapeutics inc nasdaqwint files an k financial statements and exhibits byme staff k june    share on facebook tweet on twitter windtree therapeutics inc nasdaqwint files an k financial statements and exhibits item  financial statements and exhibits d exhibits  press release dated june    presentation materials dated june   cautionary note regarding forwardlooking statements to the extent that statements in the press release presentation materials and this current report on form k are not strictly historical including statements about the companys clinical development programs including aerosurf business strategy outlook objectives plans intentions goals future financial conditions future collaboration agreements the success of the companys product development activities or otherwise as to future events such statements are forwardlooking and are made to the safe harbor provisions of the private securities litigation reform act of  all such forwardlooking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made such risks and others are further described in the companys filings with the securities and exchange commission including the most recent reports on forms k q and k and any amendments thereto windtree therapeutics inc de exhibitex  exhtm exhibit  exhtm exhibit        windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants   company to hold conference call today at  pm edt   warrington…to view the full exhibit click here about windtree therapeutics inc nasdaqwint windtree therapeutics inc formerly discovery laboratories inc is a biotechnology company the company is focused on developing kl surfactant therapies for respiratory diseases and other potential applications the company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases and the manufacture and commercial sales of approved products segment the company’s technology platform includes a synthetic peptidecontaining surfactant kl surfactant that is structurally similar to endogenous pulmonary surfactant and drug delivery technologies being developed to enable noninvasive administration of aerosolized kl surfactant the company’s core development program aerosurf lucinactant for inhalation is focused on improving the management of respiratory distress syndrome rds in premature infants a respiratory condition that can result in longterm respiratory problems developmental delay and death please enable javascript to view the comments powered by disqusan ad to help with our costs related articlesmore from author canadian pacific railway limited tsecp files an k other events duos technologies group inc otcmktsduot files an k entry into a material definitive agreement vectren corporation nysevvc files an k entry into a material definitive agreement technovative group inc otcmktstehg files an k departure of directors or certain officers election of directors appointment of certain officers compensatory arrangements of certain pacific continental corporation nasdaqpcbk files an k financial statements and exhibits mendocino brewing company inc otcmktsmenb files an k entry into a material definitive agreement subscribe to our newsletter email  first namelast nameemail a word from the sponsor latest articles pingtan marine enterprise ltd nasdaqpme files an k results of operations and financial condition rayonier advanced materials inc nyseryam files an k financial statements and exhibits armstrong world industries inc nyseawi files an k submission of matters to a vote of security holders recent posts canadian pacific railway limited tsecp files an k other events duos technologies group inc otcmktsduot files an k entry into a material definitive agreement vectren corporation nysevvc files an k entry into a material definitive agreement technovative group inc otcmktstehg files an k departure of directors or certain officers election of directors appointment of certain officers compensatory arrangements of certain officers pacific continental corporation nasdaqpcbk files an k financial statements and exhibits sponsored editor picks biotech movers johnson  johnson nysejnj and pfizer inc nysepfe july   biotech movers tesaro inc nasdaqtsro and mylan nv nasdaqmyl july   novartis ag adr nysenvs just took a big step forward in july   popular posts this small nasdaq hidden gem may have a b drug july   weekly biotech report covering – opko health inc nyseopk intercept april   facebook inc – nasdaqfb might be moving away from its april   popular categorysec filingslsestockstech newsbiotech stocksstock market newssmall capscanadapress releases about usmarket exclusive offers the latest financial news and analysis for selected us stocks and securities we are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions at market exclusive we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices market exclusive is not a registered investment brokerdealer the content on this site is for informational purposes only additionally the content on this site does not represent the views of market exclusive and is solely a representation of the authors who publish them before investing in any security you should do your own due diligence and consult with a registered broker or financial advisorcontact us email protectedfollow us sec filings stocks stock market news tech news biotech stocks featured small caps gold other news oil become a contributor about marketexclusivecom contributors advertise on market exclusive contact us  market exclusive  wint stock price  windtree therapeutics inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states wint overview compare quotes stock screener earnings calendar sectors wint us otc join td ameritrade find a broker windtree therapeutics inc watchlist createwintalert closed last updated jul    am cst delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones windtree therapeutics downgraded to hold from buy at stifel nicolaus windtree therapeutics downgraded to hold from buy at stifel nicolaus jun   at  am et by tomi kilgore tesla rebounds as musk weighs in on model s fire oct   at  pm et by sue chang in focus bulls trying to retain control aug   at  pm et by lawrence g mcmillan friday’s biggest gaining and declining stocks mar   at  pm et by kate gibson discovery labs prices shares at  discount mar   at  pm et wednesday’s biggest gaining and declining stocks mar   at  pm et by sue chang discovery labs pares gains investors digest costs mar   at  pm et stocks to watch wednesday priceline cypress mar   at  am et by marketwatch pandora down discovery labs up after hours mar   at  pm et by carla mozee discovery labs rockets on fda approval mar   at  pm et by val brickates kennedy top longs and shorts to watch mar   at  pm et by harry boxer how to play the january effect jan   at  am et by mark hulbert discovery labs responds to fda on surfaxin sep   at  am et drug stocks slide orexigen shines jun   at  pm et by val brickates kennedy discovery labs jumps  on drug analysis jun   at  am et by val brickates kennedy genzyme sanofi grab drugsector spotlight feb   at  pm et by val brickates kennedy discovery shares implode on stock offer pricing feb   at  pm et by val brickates kennedy stocks to watch forest oil discovery labs xyratex oct   at  am et on the wall street journal stocks to watch sprint citigroup life technologies apr   at  am et on the wall street journal stocks to watch cogo perfect world anthera and more mar   at  am et on the wall street journal stocks to watch cogo perfect world anthera and more mar   at  am et on the wall street journal us stocks rebound mar   at  pm et on the wall street journal stocks to watch discovery laboratories pandora media ciena and more mar   at  am et on the wall street journal stocks ride strong data higher mar   at  am et on the wall street journal recent news other news press releases week in review ihh building  billion of china hospitals seeks deals for more week in review ihh building  billion of china hospitals seeks deals for more jun   at  pm et on seeking alpha q windtree therapeutics inc de q windtree therapeutics inc de may   at  pm et on edgar online  edg  q k windtree therapeutics to delist from nasdaq windtree therapeutics to delist from nasdaq may   at  am et on seeking alpha premarket gainers as of  am apr   at  am et on seeking alpha k windtree therapeutics inc de mar   at  pm et on edgar online  edg  q k halozyme therapeutics halo worth a look stock up  jan   at  am et on zackscom top ranked income stocks to buy for november th nov   at  am et on zackscom whats in the cards for box inc box in q earnings nov   at  am et on zackscom  biotechnology stocks to sell now nov   at  am et on investorplacecom hottest manufacturing stocks now – daio amcc cytk smci oct   at  am et on investorplacecom biggest movers in manufacturing stocks now – gbt ctrv scyx aks oct   at  am et on investorplacecom hottest manufacturing stocks now – crds wint dgly ntla oct   at  pm et on investorplacecom hottest manufacturing stocks now – crbp wint ntla vjet oct   at  pm et on investorplacecom hottest manufacturing stocks now – crbp wint ntla vjet oct   at  pm et on investorplacecom biggest movers in manufacturing stocks now – abeo cris mdgl edge oct   at  pm et on investorplacecom hottest manufacturing stocks now – bspm glmd naii pbyi sep   at  am et on investorplacecom hottest manufacturing stocks now – cycc mdvn yeco bnso aug   at  pm et on investorplacecom hottest manufacturing stocks now – sphs wint mtp aimt aug   at  pm et on investorplacecom hottest manufacturing stocks now – tof auph leds rvp aug   at  am et on investorplacecom q windtree therapeutics inc de aug   at  pm et on edgar online  edg  q k delisting of securities of sears canada inc windtree therapeutics inc power solutions international inc and copsync inc from the nasdaq stock market delisting of securities of sears canada inc windtree therapeutics inc power solutions international inc and copsync inc from the nasdaq stock market jul   at  pm et on globenewswire windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants jun   at  pm et on pr newswire  prf windtree therapeutics and lees pharmaceutical hk limited enter into exclusive license and collaboration agreement for development and commercialization of kl surfactant technology platform in asia windtree therapeutics and lees pharmaceutical hk limited enter into exclusive license and collaboration agreement for development and commercialization of kl surfactant technology platform in asia jun   at  pm et on pr newswire  prf windtree announces successful completion of enrollment in aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants windtree announces successful completion of enrollment in aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants jun   at  pm et on pr newswire  prf windtree receives sbir grant in continued support of aerosurf® phase b clinical trial windtree receives sbir grant in continued support of aerosurf® phase b clinical trial may   at  pm et on pr newswire  prf windtree therapeutics reports first quarter  financial results and provides key business updates windtree therapeutics reports first quarter  financial results and provides key business updates may   at  pm et on pr newswire  prf windtree receives notice of delisting from nasdaq windtree receives notice of delisting from nasdaq may   at  pm et on pr newswire  prf windtree therapeutics and tonix pharmaceuticals on the rise after fda clinical trial news apr   at  am et on accesswire windtree announces successful completion of second and final aerosurf® phase b clinical trial interim safety review apr   at  am et on pr newswire  prf windtree therapeutics reports fourth quarter  financial results and provides key business updates mar   at  am et on pr newswire  prf windtree therapeutics aerosolized kl surfactant reduces lung inflammation and improves survival in a highpathogen avian influenza preclinical study feb   at  am et on pr newswire  prf windtree therapeutics completes  million private offering feb   at  pm et on pr newswire  prf windtree therapeutics to host a conference call and webcast at  am on thursday february   to provide clinical and financial updates feb   at  pm et on pr newswire  prf windtree therapeutics announces upcoming presentations at hot topics in neonatology dec   at  am et on pr newswire  prf windtree therapeutics aerosurf® lucinactant for inhalation phase a data presented at the  international congress of union of european neonatal and perinatal societies nov   at  pm et on pr newswire  prf windtree therapeutics to present at stifel  healthcare conference nov   at  pm et on pr newswire  prf windtree therapeutics preclinical study results show potential for kl surfactant as possible medical countermeasure to radiation exposure nov   at  pm et on pr newswire  prf windtree releases data from lung deposition study in nonhuman primates demonstrating uniform distribution of aerosolized kl surfactant in all regions of the lung oct   at  pm et on pr newswire  prf windtree therapeutics to host conference call and webcast on tuesday october   to provide a business update oct   at  pm et on pr newswire  prf windtree therapeutics announces fda fast track designation for aerosurf® sep   at  pm et on pr newswire  prf windtree therapeutics inc windtree therapeutics inc engages in the manufacture and development of products for infants and respiratory diseases it focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants its products include surfaxin and afectair the company was founded by evan myrianthopoulos and james s kuo on november   and is headquartered in warrington pa see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for june   jun   at  am et on benzingacom competitors name chg  market cap rigel pharmaceuticals inc  m idera pharmaceuticals inc  m johnson  johnson  b amerisourcebergen corp  b pharmaxis ltd adr  m competitor data provided by partner content trending tickers powered by dvax  tsla  s  ssti  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience wint key statistics  windtree therapeutics inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close windtree therapeutics inc otc wint go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus windtree therapeutics inc market closed  quotes are delayed by  min jul    am wint quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high    week low  week high   company description windtree therapeutics inc engages in the manufacture and development of products for infants and respiratory diseases it focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants windtree therapeutics inc engages in the manufacture and development of products for infants and respiratory diseases it focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants its products include surfaxin and afectair the company was founded by evan myrianthopoulos and james s kuo on november   and is headquartered in warrington pa valuation pe current  pe ratio with extraordinary items  price to sales ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on total capital  return on invested capital  capital structure total debt to total assets  officers and executives name age officer since title mr craig e fraser   president chief executive officer  director mr john andrew tattory   chief financial officer treasurer  senior vp dr steven g simonson   chief development officer  senior vice president ms kathryn a cole   senior vice presidenthuman resources ms mary b templeton   secretary senior vice president  general counsel insider actions – purchase – sale  – number of transactions  newslatestcompanyuswint marketwatch news on wint windtree therapeutics downgraded to hold from buy at stifel nicolaus  am june    tomi kilgore tesla rebounds as musk weighs in on model s fire  pm oct    sue chang in focus bulls trying to retain control  pm aug    lawrence g mcmillan friday’s biggest gaining and declining stocks  pm march    kate gibson discovery labs prices shares at  discount  pm march    marketwatchcom wednesday’s biggest gaining and declining stocks  pm march    sue chang discovery labs pares gains investors digest costs  pm march    marketwatchcom stocks to watch wednesday priceline cypress  am march    marketwatch pandora down discovery labs up after hours  pm march    carla mozee discovery labs rockets on fda approval  pm march    val brickates kennedy top longs and shorts to watch  pm march    the trading deck how to play the january effect  am jan    mark hulbert discovery labs responds to fda on surfaxin  am sept    marketwatchcom drug stocks slide orexigen shines  pm june    val brickates kennedy discovery labs jumps  on drug analysis  am june    val brickates kennedy genzyme sanofi grab drugsector spotlight  pm feb    val brickates kennedy discovery shares implode on stock offer pricing  pm feb    val brickates kennedy newsnonmarketwatchcompanyuswint other news on wint week in review ihh building  billion of china hospitals seeks deals for more  pm june    seeking alpha q windtree therapeutics inc de  pm may    edgar online  edg  q k windtree therapeutics to delist from nasdaq  am may    seeking alpha premarket gainers as of  am  am april    seeking alpha k windtree therapeutics inc de  pm march    edgar online  edg  q k halozyme therapeutics halo worth a look stock up   am jan    zackscom top ranked income stocks to buy for november th  am nov    zackscom whats in the cards for box inc box in q earnings  am nov    zackscom  biotechnology stocks to sell now  am nov    investorplacecom hottest manufacturing stocks now – daio amcc cytk smci  am oct    investorplacecom biggest movers in manufacturing stocks now – gbt ctrv scyx aks  am oct    investorplacecom hottest manufacturing stocks now – crds wint dgly ntla  pm oct    investorplacecom hottest manufacturing stocks now – crbp wint ntla vjet  pm oct    investorplacecom hottest manufacturing stocks now – crbp wint ntla vjet  pm oct    investorplacecom biggest movers in manufacturing stocks now – abeo cris mdgl edge  pm oct    investorplacecom hottest manufacturing stocks now – bspm glmd naii pbyi  am sept    investorplacecom hottest manufacturing stocks now – cycc mdvn yeco bnso  pm aug    investorplacecom hottest manufacturing stocks now – sphs wint mtp aimt  pm aug    investorplacecom hottest manufacturing stocks now – tof auph leds rvp  am aug    investorplacecom q windtree therapeutics inc de  pm aug    edgar online  edg  q k loading more headlines at a glance windtree therapeutics inc  kelly road suite  warrington pennsylvania  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for wint newspressreleasecompanyuswint press releases on wint delisting of securities of sears canada inc windtree therapeutics inc power solutions international inc and copsync inc from the nasdaq stock market  pm july    globenewswire windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants  pm june    pr newswire  prf windtree therapeutics and lees pharmaceutical hk limited enter into exclusive license and collaboration agreement for development and commercialization of kl surfactant technology platform in asia  pm june    pr newswire  prf windtree announces successful completion of enrollment in aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants  pm june    pr newswire  prf windtree receives sbir grant in continued support of aerosurf® phase b clinical trial  pm may    pr newswire  prf windtree therapeutics reports first quarter  financial results and provides key business updates  pm may    pr newswire  prf windtree receives notice of delisting from nasdaq  pm may    pr newswire  prf windtree therapeutics and tonix pharmaceuticals on the rise after fda clinical trial news  am april    accesswire windtree announces successful completion of second and final aerosurf® phase b clinical trial interim safety review  am april    pr newswire  prf windtree therapeutics reports fourth quarter  financial results and provides key business updates  am march    pr newswire  prf windtree therapeutics aerosolized kl surfactant reduces lung inflammation and improves survival in a highpathogen avian influenza preclinical study  am feb    pr newswire  prf windtree therapeutics completes  million private offering  pm feb    pr newswire  prf windtree therapeutics to host a conference call and webcast at  am on thursday february   to provide clinical and financial updates  pm feb    pr newswire  prf windtree therapeutics announces upcoming presentations at hot topics in neonatology  am dec    pr newswire  prf windtree therapeutics aerosurf® lucinactant for inhalation phase a data presented at the  international congress of union of european neonatal and perinatal societies  pm nov    pr newswire  prf windtree therapeutics to present at stifel  healthcare conference  pm nov    pr newswire  prf windtree therapeutics preclinical study results show potential for kl surfactant as possible medical countermeasure to radiation exposure  pm nov    pr newswire  prf windtree releases data from lung deposition study in nonhuman primates demonstrating uniform distribution of aerosolized kl surfactant in all regions of the lung  pm oct    pr newswire  prf windtree therapeutics to host conference call and webcast on tuesday october   to provide a business update  pm oct    pr newswire  prf windtree therapeutics announces fda fast track designation for aerosurf®  pm sept    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  wint stock price  windtree therapeutics inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states wint overview compare quotes stock screener earnings calendar sectors wint us otc join td ameritrade find a broker windtree therapeutics inc watchlist createwintalert closed last updated jul    am cst delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones windtree therapeutics downgraded to hold from buy at stifel nicolaus windtree therapeutics downgraded to hold from buy at stifel nicolaus jun   at  am et by tomi kilgore tesla rebounds as musk weighs in on model s fire oct   at  pm et by sue chang in focus bulls trying to retain control aug   at  pm et by lawrence g mcmillan friday’s biggest gaining and declining stocks mar   at  pm et by kate gibson discovery labs prices shares at  discount mar   at  pm et wednesday’s biggest gaining and declining stocks mar   at  pm et by sue chang discovery labs pares gains investors digest costs mar   at  pm et stocks to watch wednesday priceline cypress mar   at  am et by marketwatch pandora down discovery labs up after hours mar   at  pm et by carla mozee discovery labs rockets on fda approval mar   at  pm et by val brickates kennedy top longs and shorts to watch mar   at  pm et by harry boxer how to play the january effect jan   at  am et by mark hulbert discovery labs responds to fda on surfaxin sep   at  am et drug stocks slide orexigen shines jun   at  pm et by val brickates kennedy discovery labs jumps  on drug analysis jun   at  am et by val brickates kennedy genzyme sanofi grab drugsector spotlight feb   at  pm et by val brickates kennedy discovery shares implode on stock offer pricing feb   at  pm et by val brickates kennedy stocks to watch forest oil discovery labs xyratex oct   at  am et on the wall street journal stocks to watch sprint citigroup life technologies apr   at  am et on the wall street journal stocks to watch cogo perfect world anthera and more mar   at  am et on the wall street journal stocks to watch cogo perfect world anthera and more mar   at  am et on the wall street journal us stocks rebound mar   at  pm et on the wall street journal stocks to watch discovery laboratories pandora media ciena and more mar   at  am et on the wall street journal stocks ride strong data higher mar   at  am et on the wall street journal recent news other news press releases week in review ihh building  billion of china hospitals seeks deals for more week in review ihh building  billion of china hospitals seeks deals for more jun   at  pm et on seeking alpha q windtree therapeutics inc de q windtree therapeutics inc de may   at  pm et on edgar online  edg  q k windtree therapeutics to delist from nasdaq windtree therapeutics to delist from nasdaq may   at  am et on seeking alpha premarket gainers as of  am apr   at  am et on seeking alpha k windtree therapeutics inc de mar   at  pm et on edgar online  edg  q k halozyme therapeutics halo worth a look stock up  jan   at  am et on zackscom top ranked income stocks to buy for november th nov   at  am et on zackscom whats in the cards for box inc box in q earnings nov   at  am et on zackscom  biotechnology stocks to sell now nov   at  am et on investorplacecom hottest manufacturing stocks now – daio amcc cytk smci oct   at  am et on investorplacecom biggest movers in manufacturing stocks now – gbt ctrv scyx aks oct   at  am et on investorplacecom hottest manufacturing stocks now – crds wint dgly ntla oct   at  pm et on investorplacecom hottest manufacturing stocks now – crbp wint ntla vjet oct   at  pm et on investorplacecom hottest manufacturing stocks now – crbp wint ntla vjet oct   at  pm et on investorplacecom biggest movers in manufacturing stocks now – abeo cris mdgl edge oct   at  pm et on investorplacecom hottest manufacturing stocks now – bspm glmd naii pbyi sep   at  am et on investorplacecom hottest manufacturing stocks now – cycc mdvn yeco bnso aug   at  pm et on investorplacecom hottest manufacturing stocks now – sphs wint mtp aimt aug   at  pm et on investorplacecom hottest manufacturing stocks now – tof auph leds rvp aug   at  am et on investorplacecom q windtree therapeutics inc de aug   at  pm et on edgar online  edg  q k delisting of securities of sears canada inc windtree therapeutics inc power solutions international inc and copsync inc from the nasdaq stock market delisting of securities of sears canada inc windtree therapeutics inc power solutions international inc and copsync inc from the nasdaq stock market jul   at  pm et on globenewswire windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants jun   at  pm et on pr newswire  prf windtree therapeutics and lees pharmaceutical hk limited enter into exclusive license and collaboration agreement for development and commercialization of kl surfactant technology platform in asia windtree therapeutics and lees pharmaceutical hk limited enter into exclusive license and collaboration agreement for development and commercialization of kl surfactant technology platform in asia jun   at  pm et on pr newswire  prf windtree announces successful completion of enrollment in aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants windtree announces successful completion of enrollment in aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants jun   at  pm et on pr newswire  prf windtree receives sbir grant in continued support of aerosurf® phase b clinical trial windtree receives sbir grant in continued support of aerosurf® phase b clinical trial may   at  pm et on pr newswire  prf windtree therapeutics reports first quarter  financial results and provides key business updates windtree therapeutics reports first quarter  financial results and provides key business updates may   at  pm et on pr newswire  prf windtree receives notice of delisting from nasdaq windtree receives notice of delisting from nasdaq may   at  pm et on pr newswire  prf windtree therapeutics and tonix pharmaceuticals on the rise after fda clinical trial news apr   at  am et on accesswire windtree announces successful completion of second and final aerosurf® phase b clinical trial interim safety review apr   at  am et on pr newswire  prf windtree therapeutics reports fourth quarter  financial results and provides key business updates mar   at  am et on pr newswire  prf windtree therapeutics aerosolized kl surfactant reduces lung inflammation and improves survival in a highpathogen avian influenza preclinical study feb   at  am et on pr newswire  prf windtree therapeutics completes  million private offering feb   at  pm et on pr newswire  prf windtree therapeutics to host a conference call and webcast at  am on thursday february   to provide clinical and financial updates feb   at  pm et on pr newswire  prf windtree therapeutics announces upcoming presentations at hot topics in neonatology dec   at  am et on pr newswire  prf windtree therapeutics aerosurf® lucinactant for inhalation phase a data presented at the  international congress of union of european neonatal and perinatal societies nov   at  pm et on pr newswire  prf windtree therapeutics to present at stifel  healthcare conference nov   at  pm et on pr newswire  prf windtree therapeutics preclinical study results show potential for kl surfactant as possible medical countermeasure to radiation exposure nov   at  pm et on pr newswire  prf windtree releases data from lung deposition study in nonhuman primates demonstrating uniform distribution of aerosolized kl surfactant in all regions of the lung oct   at  pm et on pr newswire  prf windtree therapeutics to host conference call and webcast on tuesday october   to provide a business update oct   at  pm et on pr newswire  prf windtree therapeutics announces fda fast track designation for aerosurf® sep   at  pm et on pr newswire  prf windtree therapeutics inc windtree therapeutics inc engages in the manufacture and development of products for infants and respiratory diseases it focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants its products include surfaxin and afectair the company was founded by evan myrianthopoulos and james s kuo on november   and is headquartered in warrington pa see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for june   jun   at  am et on benzingacom competitors name chg  market cap rigel pharmaceuticals inc  m idera pharmaceuticals inc  m johnson  johnson  b amerisourcebergen corp  b pharmaxis ltd adr  m competitor data provided by partner content trending tickers powered by dvax  tsla  s  ssti  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience windtree therapeutics your browser does not support frames ticklingvideos welcome  windtree therapeutics welcome to unde omnis iste natus error sit voluptatem accusantium keep conected menu investors welcome financial information stock information sec filings corporate presentation events  conference calls press releases investor alerts welcome windtree therapeutics is a specialty biotechnology company focused on advancing a new standard in respiratory critical care windtree therapeutics technology platform includes its novel proprietary kl surfactant a synthetic peptidecontaining surfactant that is structurally similar to pulmonary surfactant and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized kl surfactant and other inhaled therapies  windtree therapeutics strategy is initially focused on neonatology and improving the management of respiratory distress syndrome rds in premature infants windtree therapeutics believes that its rds product portfolio has the potential to become the new standard of care for rds and over time enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy but are currently not treated recent news jun  windtree announces topline results from aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants jun  windtree therapeutics and lees pharmaceutical hk limited enter into exclusive license and collaboration agreement for development and commercialization of kl surfactant technology platform in asia jun  windtree announces successful completion of enrollment in aerosurf® phase b clinical trial for the treatment of respiratory distress syndrome rds in premature infants otcqb wintnasdaq dsco dymomoyryr